SKIN 
 

May 2023     Volume 7 Issue 3 
 

(c) 2023 THE AUTHORS. Published by the National Society for Cutaneous Medicine. 840 

BRIEF ARTICLE 
 

 

A Case of a Large, Painful Dermatofibrosarcoma Protuberans 
Arising from a Traumatic Scar 
 

Daniel L. Fischer, DO, MA1, Graham Litchman, DO, MS1 
 
1St. John’s Episcopal Hospital, Far, Rockaway, NY  
 

 

 
 

 
 
Dermatofibrosarcoma protuberans (DFSP) is 
a rare, locally aggressive and seldom 
metastatic soft tissue tumor usually confined 
to the dermis and subcutaneous tissues.1 
The first case of DFSP was described in 1924 
and termed by Hoffman in 1925.2 It accounts 
for less than 0.1% of all malignant neoplasms 
and 1% of soft tissue sarcomas.3 Diagnosis 
requires skin biopsy with histochemical 
analysis and mainstay of treatment is 
surgery. It is most commonly seen among 
adults in their thirties, with a predominance in 
blacks.4 Most lesions are no more than 5 cm 
in diameter and occur spontaneously.5 Here 
we describe a case of DFSP that arose within 
a preexisting scar and grew to much larger 
proportions than what is typically observed. 
 

 
 

Our case involves a 35-year-old Caucasian 
man who presented to the emergency 
department for 10/10 sharp, squeezing chest 
pain originating at the site of a left chest 
mass. The mass had formed out of an area 
of scar tissue that had developed after a 
traumatic motor vehicle accident. However, 
the tissue had formed a mass and grew 
exponentially over the past two months 
(Figure 1). During this time the mass became 
increasingly painful causing intermittent 
episodes of stabbing pain, radiating to the 
back, lasting about 20 seconds, and recurring 
throughout the day. The patient had not 
sought medical help during this time due to 
lack of insurance. 
 
Physical examination was remarkable for a 
large, multilobulated, highly vascular chest 
wall mass localized to the left sternal border 
measuring approximately 10 by 12 
centimeters (cm) with well-demarcated 
margins. The lower portion of the mass was 
firm to palpation while the upper portion was 

ABSTRACT 

Here we report a case of a patient with dermatofibrosarcoma protuberans (DFSP) that 
presented originally to the emergency department with chief complaint of ‘chest pain arising 
from a chest wall mass’. This case is unique for multiple reasons including the fact that the 
DFSP caused this patient severe pain that radiated from the site of the mass to the patient’s 
back. The lesion originated from a traumatic scar that the patient had obtained following a car 
accident two years prior to presentation. In addition, the DFSP was significantly larger in size 
than what has typically been reported in the literature. This case illustrates that DFSP has the 
potential to present with multiple atypical features. 

INTRODUCTION 

CASE REPORT 

https://paperpile.com/c/M1sVg8/woJF
https://paperpile.com/c/M1sVg8/uiLo
https://paperpile.com/c/M1sVg8/9mZv
https://paperpile.com/c/M1sVg8/yvaY
https://paperpile.com/c/M1sVg8/lGJ5


SKIN 
 

May 2023     Volume 7 Issue 3 
 

(c) 2023 THE AUTHORS. Published by the National Society for Cutaneous Medicine. 841 

soft. The mass was also highly sensitive to 
touch. The differential diagnosis included 
arteriovenous malformation, soft tissue 
hemangioma, and soft tissue sarcoma. 
 

 
Figure 1. A large, highly vascular left-sided chest wall 
mass measuring 10 by 12 centimeters that was 
identified to be a DFSP on histology. 

CT chest revealed an 11.3 by 8.8 by 6.3 cm 
left anterior chest wall mass located in the 
subcutaneous tissue with no evidence of 
muscle or bony invasion. MRI chest revealed 
multiple well-circumscribed, grape-like 
hypervascular masses in the subcutaneous 
soft tissue of the left anterior chest wall. 
There was predominant vascular supply from 
the intercostal and internal mammary chain 
vascular structures. No evidence of chest 
wall invasion was appreciated. 
 
Ultrasound-guided core needle biopsy 
showed a relatively monotonous spindle cell 
proliferation with storiform architecture 
throughout. Immunohistochemistry showed 
positivity for CD34 and vimentin, and 
negative for S100, desmin, EMA, and CD68. 
Ki67 index was brisk and STAT-6 and Factor 
XIII were negative. The interpretation was 

read as spindle cell neoplasm of intermediate 
grade favoring DFSP. 
 

 
 
Dermatofibrosarcoma protuberans typically 
presents as a slow growing, nontender 
plaque that with time develops an 
asymmetric and multinodular, red, yellow, or 
brown appearance.1 DFSP most commonly 
appears on the trunk or extremities and less 
often on the head and neck but can appear 
almost anywhere.3 Local recurrence 
following excision is fairly common.4 With 
treatment, the prognosis is excellent (10-year 
survival rate of 99.1%).4 DFSPs are typically 
asymptomatic which makes this case 
particularly unique as our patient was 
symptomatic with severe pain at the site of 
the lesion, and the prime reason for him 
seeking medical attention.  
 
The cause of DFSP is not known but prior 
studies suggest that translocations between 
chromosomes 17 and 22 may play a role in 
their development. This translocation is 
thought to cause an upregulation of the 
platelet-derived growth factor beta 
polypeptide gene leading to cellular 
proliferation.6 According to several studies, it 
is estimated that up to 10-20% of DFSP have 
arisen from prior trauma.7-9 This was the case 
in our patient, as his malignancy had arisen 
from a scar that he had acquired after a motor 
vehicle injury two years prior to his 
presentation at our hospital.  
 
Diagnosis of DFSP is confirmed via incisional 
or excisional biopsy. This can often be 
challenging if the lesion is highly vascular, as 
in our case. In this scenario, an MRI of the 
lesion was done to map the vascular regions 
and define tumor extension. This was 
followed by a core-needle biopsy without 
complication. Examination of hematoxylin 

DISCUSSION 

https://paperpile.com/c/M1sVg8/woJF
https://paperpile.com/c/M1sVg8/9mZv
https://paperpile.com/c/M1sVg8/yvaY
https://paperpile.com/c/M1sVg8/yvaY
https://paperpile.com/c/M1sVg8/5SI4
https://paperpile.com/c/M1sVg8/us0y


SKIN 
 

May 2023     Volume 7 Issue 3 
 

(c) 2023 THE AUTHORS. Published by the National Society for Cutaneous Medicine. 842 

and eosin-stained specimens by light 
microscopy yields the diagnosis.1 Pathology 
typically reveals monotonous spindle cell 
proliferation with storiform architecture 
throughout with positivity for CD34 and 
vimentin and negative staining for Factor XIII, 
S-100, CD68, and 5% positivity for Ki67.10 
This correlated with the histopathology 
findings in our patient. 
 
When the diagnosis of a large DFSP is 
suspect, a multidisciplinary approach is 
recommended with tertiary center evaluation. 
The standard treatment for DFSP is surgical 
removal with Mohs micrographic surgery 
(MMS). This method is preferred over wide 
excision as it ensures complete removal of 
tumor margins and is appropriate in cases 
like DFSP in which the depth of extension is 
highly unpredictable. It also reduces the 
likelihood of tumor recurrence (1% with MMS; 
7.3% with wide excision). In the rare scenario 
that DFSP has metastasized or is 
unresectable, chemotherapy with imatinib 
mesylate or radiation therapy may be used.2 
Close follow up is required post-treatment 
and evaluation ideally every 3-6 months due 
to the high recurrence rate of DFSP. Our 
patient was scheduled for treatment by MMS 
at a specialized surgical institute. 
 

 
 
Although DFSP is a rare disease with 
definitive treatment and good prognosis, its 
high rate of misdiagnosis and potential for 
delay in management can lead to poorer 
outcomes and more complex treatment.  It is 
important for primary care physicians, 
dermatologists, surgeons, and pathologists 
to be clinically suspicious of this tumor and its 
variations in presentation in order to 
diagnosis and treat early. Post-operative 
management is critical, as these lesions have 
a high rate of recurrence. Thus, physicians 

should pay close attention to patient history 
of prior DFSP and changing appearance of 
scar tissue in their clinical evaluation. 
 
Conflict of Interest Disclosures: None 
 
Funding: None 
 
Corresponding Author: 
Daniel Fischer, DO, MA 
St. John’s Episcopal Hospital 
Far Rockaway, NY 
Email: drdeefish@gmail.com 

 
 
References: 
1. Wu S, Huang Y, Li Z, Wu H, Li H. Collagen 

Features of Dermatofibrosarcoma 
Protuberans Skin Base on Multiphoton 
Microscopy. Technol Cancer Res Treat. 
2018;17:1533033818796775. 

2. Angouridakis N, Kafas P, Jerjes W, et al. 
Dermatofibrosarcoma protuberans with 
fibrosarcomatous transformation of the head 
and neck. Head Neck Oncol. 2011;3:5. 

3. Harati K, Lange K, Goertz O, et al. A single-
institutional review of 68 patients with 
dermatofibrosarcoma protuberans: wide re-
excision after inadequate previous surgery 
results in a high rate of local control. World J 
Surg Oncol. 2017;15(1):5. 

4. Kreicher KL, Kurlander DE, Gittleman HR, 
Barnholtz-Sloan JS, Bordeaux JS. Incidence 
and Survival of Primary 
Dermatofibrosarcoma Protuberans in the 
United States. Dermatol Surg. 2016;42 Suppl 
1:S24-S31. 

5. Archontaki M, Korkolis DP, Arnogiannaki N, 
et al. Dermatofibrosarcoma protuberans: a 
case series of 16 patients treated in a single 
institution with literature review. Anticancer 
Res. 2010;30(9):3775-3779. 

6. Lemm D, Mügge LO, Mentzel T, Höffken K. 
Current treatment options in 
dermatofibrosarcoma protuberans. J Cancer 
Res Clin Oncol. 2009;135(5):653-665. 

7. de Araujo RN, Marcarini R, Ferreira BDFM, 
Obadia DL. Dermatofibrosarcoma 
protuberans rapid growth after incisional 
biopsy. Medicina Cutánea Ibero-Latino-
Americana. 2017;45(1):41-44. 

8. Tanaka A, Hatoko M, Tada H, Kuwahara M, 
Iioka H, Niitsuma K. Dermatofibrosarcoma 
protuberans arising from a burn scar of the 
axilla. Ann Plast Surg. 2004;52(4):423-425. 

CONCLUSION 

https://paperpile.com/c/M1sVg8/woJF
https://paperpile.com/c/M1sVg8/tl31
https://paperpile.com/c/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/woJF
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/uiLo
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/9mZv
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/yvaY
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/lGJ5
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/5SI4
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/us0y
http://paperpile.com/b/M1sVg8/8yfM
http://paperpile.com/b/M1sVg8/8yfM
http://paperpile.com/b/M1sVg8/8yfM
http://paperpile.com/b/M1sVg8/8yfM
http://paperpile.com/b/M1sVg8/8yfM
http://paperpile.com/b/M1sVg8/8yfM


SKIN 
 

May 2023     Volume 7 Issue 3 
 

(c) 2023 THE AUTHORS. Published by the National Society for Cutaneous Medicine. 843 

9. Saeki H, Kadono T, Le Pavoux A, Mori E, 
Tamaki K. Dermatofibrosarcoma protuberans 
with COL1A1-PDGFB fusion transcript 
arising on a scar due to a previous drainage 
tube insertion. J Dermatol. 2008;35(10):686-
688. 

10. Yang H, Yu L. Cutaneous and Superficial 
Soft Tissue CD34+ Spindle Cell Proliferation. 
Arch Pathol Lab Med. 2017;141(8):1092-
1100. 

 
  

http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/QbJw
http://paperpile.com/b/M1sVg8/tl31
http://paperpile.com/b/M1sVg8/tl31
http://paperpile.com/b/M1sVg8/tl31
http://paperpile.com/b/M1sVg8/tl31
http://paperpile.com/b/M1sVg8/tl31